# Lanlan Pang

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/lanlan-pang/

## Facts

| Field | Value |
| --- | --- |
| Citations | 511 |
| Field | Lung Cancer Treatments and Mutations |
| h-index | 13 |
| i10-index | 13 |
| Last Known Institution | Sun Yat-sen University |
| OpenAlex ID | https://openalex.org/A5046017937 |
| ORCID iD | 0000-0002-4932-8117 |
| Works | 64 |

## Researcher papers

- [Role of Telemedicine in Inflammatory Bowel Disease: Systematic Review and Meta-analysis of Randomized Controlled Trials](https://scholariq.org/papers/role-of-telemedicine-in-inflammatory-bowel-disease-systematic-review-and-meta/)
- [EGFR Oncogenic Mutations in NSCLC Impair Macrophage Phagocytosis and Mediate Innate Immune Evasion Through Up-Regulation of CD47](https://scholariq.org/papers/egfr-oncogenic-mutations-in-nsclc-impair-macrophage-phagocytosis-and-mediate/)
- [The role of the CDCA gene family in ovarian cancer](https://scholariq.org/papers/the-role-of-the-cdca-gene-family-in-ovarian-cancer/)
- [Telemonitor care helps CPAP compliance in patients with obstructive sleep apnea: a systemic review and meta-analysis of randomized controlled trials](https://scholariq.org/papers/telemonitor-care-helps-cpap-compliance-in-patients-with-obstructive-sleep-apnea/)
- [The effects of telemedicine on the quality of life of patients with lung cancer: a systematic review and meta-analysis](https://scholariq.org/papers/the-effects-of-telemedicine-on-the-quality-of-life-of-patients-with-lung-cancer/)
- [Analysis of the Expression of <i>Cell Division Cycle-Associated</i> Genes and Its Prognostic Significance in Human Lung Carcinoma: A Review of the Literature Databases](https://scholariq.org/papers/analysis-of-the-expression-of-i-cell-division-cycle-associated-i-genes-and-its/)
- [Exploration of immunotherapy in advanced pulmonary lymphoepithelioma‐like carcinoma](https://scholariq.org/papers/exploration-of-immunotherapy-in-advanced-pulmonary-lymphoepithelioma-like/)
- [HER2 Amplification in Advanced NSCLC Patients After Progression on EGFR-TKI and Clinical Response to EGFR-TKI Plus Pyrotinib Combination Therapy](https://scholariq.org/papers/her2-amplification-in-advanced-nsclc-patients-after-progression-on-egfr-tki-and/)
- [Efficacy and potential resistance mechanisms of afatinib in advanced non–small cell lung cancer patients with <scp>EGFR G719X</scp>/<scp>L861Q</scp>/<scp>S768I</scp>](https://scholariq.org/papers/efficacy-and-potential-resistance-mechanisms-of-afatinib-in-advanced-non-small/)
- [Combination era, using combined vasopressors showed benefits in treating septic shock patients: a network meta-analysis of randomized controlled trials](https://scholariq.org/papers/combination-era-using-combined-vasopressors-showed-benefits-in-treating-septic/)
- [Rare transformation from lung adenocarcinoma to sarcomatoid carcinoma mediates resistance to inhibitors targeting different driver oncogenes](https://scholariq.org/papers/rare-transformation-from-lung-adenocarcinoma-to-sarcomatoid-carcinoma-mediates/)

## Researcher topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)

## Researcher university

- [Sun Yat-sen University](https://scholariq.org/institutions/sun-yat-sen-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.